Evidence map›Paper›PMID 37382074›Full record

ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2023

Cellular Recycling Gone Wrong: The Role of Dysregulated Autophagy and Hyperactive mTORC1 in the Pathogenesis of Sarcoidosis.

Jennifer Adouli, Aaron Fried, Rachel Swier, Andrew Ghio, Irina Petrache, Stephen Tilley

Open access · greenAbstract read
In one paragraph

Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. New Therapies for Sarcoidosis: Molecular and Pathophysiological Basis.International journal of molecular sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jennifer AdouliDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA; UNC Sarcoidosis Center, University of North Carolina at Chapel Hill, Chapel Hill, USA. jennifer_adouli@med.unc.edu.
Aaron FriedDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA. aaron.fried@unchealth.unc.edu.
Rachel SwierDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA; UNC Sarcoidosis Center, University of North Carolina at Chapel Hill, Chapel Hill, USA. rachel_swier@med.unc.edu.
Andrew GhioUNC Sarcoidosis Center, University of North Carolina at Chapel Hill, Chapel Hill, USA; National Health and Environmental Effects Research Laboratory, Environmental Protection Agency, Chapel Hill, USA. aghio@email.unc.edu.
Irina PetracheDivision of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, USA. PetracheI@NJHealth.org.
Stephen TilleyDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA; UNC Sarcoidosis Center, University of North Carolina at Chapel Hill, Chapel Hill, USA. stephen_tilley@med.unc.edu.
University of North Carolina at Chapel Hill · USEnvironmental Protection Agency · USNational Jewish Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsAutophagy is a highly regulated, complex intracellular recycling process that is vital to maintaining cellular homeostasis in response to diverse conditions and stressors. Despite the presence of robust regulatory pathways, the intricate and multi-step nature of autophagy creates opportunity for dysregulation. Errors in autophagy have been implicated in the development of a broad range of clinical pathologies including granulomatous disease. Specifically, activation of the mTORC1 pathway has been identified as a key negative regulator of autophagic flux, prompting the study of dysregulated mTORC1 signaling in the pathogenesis of sarcoidosis. Our review: We conducted a thorough search of the extant literature to identify the regulatory pathways of autophagy, and more specifically the implication of upregulated mTORC1 pathways in the pathogenesis of sarcoidosis. We review data showing spontaneous granuloma formation in animal models with upregulate mTORC1 signaling, human genetic studies showing mutation in autophagy genes in sarcoidosis patients, and clinical data showing that targeting autophagy regulatory molecules like mTORC1 may provide new therapeutic approaches for sarcoidosis.

conclusionsGiven the incomplete understanding of sarcoidosis pathogenesis and the toxicities of current treatments, a more complete understanding of sarcoidosis pathogenesis is crucial for the development of more effective and safer therapies. In this review, we propose a strong molecular pathway driving sarcoidosis pathogenesis at which autophagy is at the center. A more complete understanding of autophagy and its regulatory molecules, like mTORC1, may provide a window into new therapeutic approaches for sarcoidosis.

Identifiers

PMID37382074
PMCPMC10494747
OpenAlexW4382501442

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.